HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Durbin Bill Would Narrow Definition Of Dietary Supplement

This article was originally published in The Tan Sheet

Executive Summary

Legislation Sen. Dick Durbin offers to stop firms from allegedly side-stepping food safety standards by labeling products as dietary supplements could have a "devastating impact on the industry," stakeholders say.

You may also be interested in...



FDA Supplement Enforcement Priorities Go Beyond NDI Notification

FDA’s plan to tighten enforcement of new dietary ingredient notifications with its controversial guidance still in draft form raises concerns for some stakeholders.

FDA Oversteps Supplement Authority With NDI Notification Guidance – Hatch

FDA overstepped its authority to regulate supplements with the new dietary ingredient notification draft guidance, says Sen. Orrin Hatch.

Suggested Supplement Registry To Root Out Spiked Products Sparks Debate

A suggestion that a dietary supplement registry could help FDA weed out spiked supplements drew fire at the Council for Responsible Nutrition's conference in Lost Pines, Texas

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel